Uncategorized

ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come

ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come

Published

on

Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data are expected later this year.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version